Luise Weigand

Company: Zelluna Immunotherapy

Job title: Head Of Research

Seminars:

The Best of Both Worlds: How TCRs Synergize with the Innate Activity of NK Cells 11:30 am

Addressing tumor heterogeneity with dual targeting Avoiding tumor escape mechanisms  Delivering an allogeneic off-the-shelf NK cell therapyRead more

day: Day 2

Panel Discussion: Evaluating the Cell vs Bispecific Evolution to Elevate Their Respective Advantages 10:00 am

• Consolidating the clinical advances for both approaches while highlighting the next generation for each method • Comparing clinical efficacy and safety data to highlight benefits and challenges of each modality • Discussing how the impact of various targets and TCR enhancements may differ for each approach to determine priorities for future modification • Reflecting…Read more

day: Day 1